ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION

Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E498-E498
Hauptverfasser: Rasoul, Saman, van't Hof, Arnoud, Clare, Robert, Atar, Dan, James, Stefan, Tanguay, Jean-Francois, Betriu, Amadeo, brogan, gerard, Giugliano, Robert, Newby, L. Kristin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E498
container_issue 13
container_start_page E498
container_title Journal of the American College of Cardiology
container_volume 59
creator Rasoul, Saman
van't Hof, Arnoud
Clare, Robert
Atar, Dan
James, Stefan
Tanguay, Jean-Francois
Betriu, Amadeo
brogan, gerard
Giugliano, Robert
Newby, L. Kristin
description Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).
doi_str_mv 10.1016/S0735-1097(12)60499-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1547354205</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0735109712604999</els_id><sourcerecordid>3380338311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1855-bd9cb7f4b95af8e5dfd3bcd988bef2bcc232f44748187b5e29c671a51729f4483</originalsourceid><addsrcrecordid>eNqFkdGO1CAUhonRxHH1EUxIvNHEKtAyhRtNbZldkhk6KYxmvCEtpUnXcWYtuyb7JL6uzMxGE2-8InC-_wPOAeAlRu8wwvP3GuUpTTDi-WtM3sxRxnnCH4EZppQlKeX5YzD7gzwFz0K4RgjNGeYz8KupN0YqAUXRLLdQrI1cyE-FkZV4C6VaFE1poJZf465QFYxwWa-EjiWoapVok2hxuRLKQLEUn2OuVrAoN0bAsm5qVTRbqLeqamIIrmM5khp-kebqgRcVNE29rlUUHqPVSmodJc_Bk6HdBf_iYb0Am4Uw5VWyrC9lWSwThxmlSddz1-VD1nHaDszTfujTzvWcsc4PpHOOpGTIsjxjmOUd9YS7eY5binPC4zlLL8Crs_dmOvy48-HWXh_upn280mKaxaZlBNFI0TPlpkMIkx_szTR-b6d7i5E9zsCeZmCPDbaY2NMMLI-5j-ecj1_4OfrJBjf6vfP9OHl3a_vD-F_Dh38MbjfuR9fuvvl7H_4-1gZi0VlydGByMvD0N4U5l04</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547354205</pqid></control><display><type>article</type><title>ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rasoul, Saman ; van't Hof, Arnoud ; Clare, Robert ; Atar, Dan ; James, Stefan ; Tanguay, Jean-Francois ; Betriu, Amadeo ; brogan, gerard ; Giugliano, Robert ; Newby, L. Kristin</creator><creatorcontrib>Rasoul, Saman ; van't Hof, Arnoud ; Clare, Robert ; Atar, Dan ; James, Stefan ; Tanguay, Jean-Francois ; Betriu, Amadeo ; brogan, gerard ; Giugliano, Robert ; Newby, L. Kristin</creatorcontrib><description>Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(12)60499-9</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Acute coronary syndromes ; Angina pectoris ; Cardiology ; Cardiovascular ; Heart attacks ; Internal Medicine</subject><ispartof>Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E498-E498</ispartof><rights>American College of Cardiology Foundation</rights><rights>2012 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 27, 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109712604999$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Rasoul, Saman</creatorcontrib><creatorcontrib>van't Hof, Arnoud</creatorcontrib><creatorcontrib>Clare, Robert</creatorcontrib><creatorcontrib>Atar, Dan</creatorcontrib><creatorcontrib>James, Stefan</creatorcontrib><creatorcontrib>Tanguay, Jean-Francois</creatorcontrib><creatorcontrib>Betriu, Amadeo</creatorcontrib><creatorcontrib>brogan, gerard</creatorcontrib><creatorcontrib>Giugliano, Robert</creatorcontrib><creatorcontrib>Newby, L. Kristin</creatorcontrib><title>ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION</title><title>Journal of the American College of Cardiology</title><description>Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).</description><subject>Acute coronary syndromes</subject><subject>Angina pectoris</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Heart attacks</subject><subject>Internal Medicine</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFkdGO1CAUhonRxHH1EUxIvNHEKtAyhRtNbZldkhk6KYxmvCEtpUnXcWYtuyb7JL6uzMxGE2-8InC-_wPOAeAlRu8wwvP3GuUpTTDi-WtM3sxRxnnCH4EZppQlKeX5YzD7gzwFz0K4RgjNGeYz8KupN0YqAUXRLLdQrI1cyE-FkZV4C6VaFE1poJZf465QFYxwWa-EjiWoapVok2hxuRLKQLEUn2OuVrAoN0bAsm5qVTRbqLeqamIIrmM5khp-kebqgRcVNE29rlUUHqPVSmodJc_Bk6HdBf_iYb0Am4Uw5VWyrC9lWSwThxmlSddz1-VD1nHaDszTfujTzvWcsc4PpHOOpGTIsjxjmOUd9YS7eY5binPC4zlLL8Crs_dmOvy48-HWXh_upn280mKaxaZlBNFI0TPlpkMIkx_szTR-b6d7i5E9zsCeZmCPDbaY2NMMLI-5j-ecj1_4OfrJBjf6vfP9OHl3a_vD-F_Dh38MbjfuR9fuvvl7H_4-1gZi0VlydGByMvD0N4U5l04</recordid><startdate>20120327</startdate><enddate>20120327</enddate><creator>Rasoul, Saman</creator><creator>van't Hof, Arnoud</creator><creator>Clare, Robert</creator><creator>Atar, Dan</creator><creator>James, Stefan</creator><creator>Tanguay, Jean-Francois</creator><creator>Betriu, Amadeo</creator><creator>brogan, gerard</creator><creator>Giugliano, Robert</creator><creator>Newby, L. Kristin</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20120327</creationdate><title>ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION</title><author>Rasoul, Saman ; van't Hof, Arnoud ; Clare, Robert ; Atar, Dan ; James, Stefan ; Tanguay, Jean-Francois ; Betriu, Amadeo ; brogan, gerard ; Giugliano, Robert ; Newby, L. Kristin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1855-bd9cb7f4b95af8e5dfd3bcd988bef2bcc232f44748187b5e29c671a51729f4483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute coronary syndromes</topic><topic>Angina pectoris</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Heart attacks</topic><topic>Internal Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rasoul, Saman</creatorcontrib><creatorcontrib>van't Hof, Arnoud</creatorcontrib><creatorcontrib>Clare, Robert</creatorcontrib><creatorcontrib>Atar, Dan</creatorcontrib><creatorcontrib>James, Stefan</creatorcontrib><creatorcontrib>Tanguay, Jean-Francois</creatorcontrib><creatorcontrib>Betriu, Amadeo</creatorcontrib><creatorcontrib>brogan, gerard</creatorcontrib><creatorcontrib>Giugliano, Robert</creatorcontrib><creatorcontrib>Newby, L. Kristin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rasoul, Saman</au><au>van't Hof, Arnoud</au><au>Clare, Robert</au><au>Atar, Dan</au><au>James, Stefan</au><au>Tanguay, Jean-Francois</au><au>Betriu, Amadeo</au><au>brogan, gerard</au><au>Giugliano, Robert</au><au>Newby, L. Kristin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2012-03-27</date><risdate>2012</risdate><volume>59</volume><issue>13</issue><spage>E498</spage><epage>E498</epage><pages>E498-E498</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(12)60499-9</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E498-E498
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_1547354205
source Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Acute coronary syndromes
Angina pectoris
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
title ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A22%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ROUTINE%20EARLY%20EPTIFIBATIDE,%20INFARCT%20SIZE,%20AND%20OUTCOMES%20IN%20NON-ST-SEGMENT%20ELEVATION%20ACUTE%20CORONARY%20SYNDROME%20PATIENTS%20WITH%20ELEVATED%20TROPONIN%20ON%20ADMISSION&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Rasoul,%20Saman&rft.date=2012-03-27&rft.volume=59&rft.issue=13&rft.spage=E498&rft.epage=E498&rft.pages=E498-E498&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(12)60499-9&rft_dat=%3Cproquest_cross%3E3380338311%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1547354205&rft_id=info:pmid/&rft_els_id=1_s2_0_S0735109712604999&rfr_iscdi=true